Journal of Chest Surgery

The Korean Society for Thoracic and Cardiovascular Surgery (대한심장혈관흉부외과학회)
권호 표지
DOI QR코드

DOI QR Code

Commentary: Preoperative versus Intraoperative Tissue Diagnosis in Highly Suspicious Stage I Lung Cancer: Which Is the Superior Approach?

  • Jeong Su Cho (Department of Thoracic and Cardiovascular Surgery, Medical Research Institution, Pusan National University Hospital)
  • Received : 2024.07.15
  • Accepted : 2024.07.15
  • Published : 2024.09.05
Download PDF
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. Nakajima J, Sato H, Takamoto S. Does preoperative transbronchial biopsy worsen the postsurgical prognosis of lung cancer?: a propensity score-adjusted analysis. Chest 2005;128:3512-8. https://doi.org/10.1378/chest.128.5.3512
  2. Taniguchi Y, Fukumoto K, Matsui H, Saito T, Murakawa T. Preoperative biopsy does not affect postoperative outcomes of resectable non-small cell lung cancer. Gen Thorac Cardiovasc Surg 2019;67:615-23. https://doi.org/10.1007/s11748-019-01062-1
  3. Sihoe AD, Hiranandani R, Wong H, Yeung ES. Operating on a suspicious lung mass without a preoperative tissue diagnosis: pros and cons. Eur J Cardiothorac Surg 2013;44:231-7. https://doi.org/10.1093/ejcts/ezs671
  4. Sawabata N, Maeda H, Ohta M, Hayakawa M. Operable non-small cell lung cancer diagnosed by transpleural techniques : do they affect relapse and prognosis? Chest 2001;120:1595-8. https://doi.org/10.1378/chest.120.5.1595
  5. Klarenbeek SE, Aarts MJ, van den Heuvel MM, Prokop M, Tummers M, Schuurbiers OC. Impact of time-to-treatment on survival for advanced non-small cell lung cancer patients in the Netherlands: a nationwide observational cohort study. Thorax 2023;78:467-75. https://doi.org/10.1136/thoraxjnl-2021-218059
  6. Kara M, Erdogdu E, Duman S, Fatalizade G, Ozkan B, Toker A. Potential survival benefit of upfront surgery for lung tumors unconfirmed but highly suspicious for stage I lung cancer. J Chest Surg 2024 Jun 5 [Epub]. https://doi.org/10.5090/jcs.23.166
  7. Onwugbufor MT, Soni ML, Predina JD, et al. Lobectomy for suspected lung cancer without prior diagnosis. Ann Thorac Surg 2023;116:694-701. https://doi.org/10.1016/j.athoracsur.2023.05.017
  8. Abe J, Okazaki T, Kikuchi N, Takahashi S, Sakurada A, Okada Y. Preoperative bronchoscopic cancer confirmation does not increase risk of recurrence in stage1A non-small cell lung cancer. Gen Thorac Cardiovasc Surg 2018;66:284-90. https://doi.org/10.1007/s11748-018-0909-y
  9. Inoue M, Honda O, Tomiyama N, et al. Risk of pleural recurrence after computed tomographic-guided percutaneous needle biopsy in stage I lung cancer patients. Ann Thorac Surg 2011;91:1066-71. https://doi.org/10.1016/j.athoracsur.2010.12.032
  10. National Comprehensive Cancer Network. NCCN guideline version 7.2024: non-small cell cancer: principles of diagnostic evaluation. National Comprehensive Cancer Network; 2024.
  11. Mack SJ, Collins ML, Whitehorn GL, et al. Intraoperative versus preoperative diagnosis of lung cancer: differences in treatments and patient outcomes. Clin Lung Cancer 2023;24:726-32. https://doi.org/10.1016/j.cllc.2023.07.002